How do we achieve cost-effective options in lower respiratory tract infection therapy?

Chest

Volumn 113, Issue 3 SUPPL., 1998, Pages 205S-210S

  Grossman, Ronald F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; DOXYCYCLINE; MACROLIDE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIOLOGY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; DRUG INDICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TREATMENT OUTCOME;

EID: 0031894706     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.3_Supplement.205S     Document Type: Article

References (63)

1. US Bureau of the Census. Statistical abstract of the United States: 1994. 114th ed. Washington, DC: US Bureau of the Census, 1994; 95
2. Woolcock AJ. Epidemiology of chronic airways disease. Chest 1989; 96(suppl 3):302S-06S
3. Garibaldi RA. Epidemiology of community acquired respiratory tract infections in adults: incidence, etiology, and impact. Am J Med 1985; 78(suppl 6B):32-37
4. Verheij TJM, Kaptein AA, Mulder JD. Acute bronchitis: etiology, symptoms and treatment. J Fam Pract 1989; 6:66-69
5. Morrell DC. Expressions of morbidity in general practice. BMJ 1971; 2:454-58
6. Turner-Warwick M, Hodson ME, Corrin B, et al. Clinical atlas of respiratory diseases. London: Cower Medical Publishing, 1990
7. Intercontinental Medical Statistics (IMS). Ruislip, Middlesex: BPI/MDI, 1993
8. Huchon GJ, Gialdroni-Grassi G, Leophonte P, et al. Initial antibiotic therapy for lower respiratory tract infection in the Community: a European survey. Eur Respir J 1996; 9:1590-95
9. Dorca J, Torres A. Lower respiratory tract infections in the community: towards a more rational approach. Eur Respir J 1996; 9:1588-89
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-44
11. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965; 1:775-79
12. Burrows B, Lebowitz MD. Quantitative relationships between cigarette smoking and chronic productive cough. Int J Epidemiol 1977; 6:107-13
13. Xu X, Christiani DC, Dockery DW, et al. Exposure-response relationships between occupational exposures and chronic illness: a community-based study. Am Rev Respir Dis 1992; 146:413-18
14. Burge PS. Occupation and chronic obstructive pulmonary disease (COPD). Eur Respir J 1994; 7:1032-34
15. Matsuse T, Hayashi S, Kuwano K, et al. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146:177-84
16. Fielding JE, Phenow KJ. Health effects of involuntary smoking. N Engl J Med 1988; 319:1452-60
17. Anthonisen NR, Manfreda J, Warren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive lung disease. Ann Intern Med 1987; 106:196-204
18. Gump DW, Phillips CA, Forsyth BR, et al. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976; 113:465-73
19. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1:1645-48
20. Schmidt GA, Hall JB. Acute or chronic respiratory failure: assessment and management of patients with COPD in the emergent setting. JAMA 1989; 261:3444-53
21. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbations of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154:959-67
22. Tager I, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med 1975; 292:563-71
23. Fisher M, Akhtar AJ, Calder MA, et al. Pilot study of factors associated with exacerbations of chronic bronchitis. BMJ 1969; 4:187-92
24. Medici TC, Chodosh S. The reticuloendothelial system in chronic bronchitis. Am Rev Respir Dis 1972; 105:792-804
25. Musher DM, Kubutschek KR, Crennon J, et al. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 1983; 99:444-50
26. Stockley RA, Burnett D. Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infections. Bull Eur Physiopathol Respir 1980; 16:261-71
27. Murphy TF, Seithi S. State of the art: bacterial infection in chronic obstructive lung disease. Am Rev Respir Dis 1992; 146:1067-83
28. Saint S, Bent S, Vittinghoff E, et al. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995; 273:957-60
29. Chodosh S. Acute bacterial exacerbations in bronchitis and asthma. Am J Med 1987; 82(suppl 4A):154-63
30. Fagon J-Y, Chastre J, Trouillet J-L, et al. Characterization of the distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Respir Dis 1990; 142:1004-08
31. Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease: a study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152:1316-20
32. Groeneveld K, van Alphen L, Eijk PP, et al. Endogenous and exogenous reinfections with Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis 1990; 161:512-17
33. Kayser FH, Morenzoni G, Santanam P. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 1990; 9:810-17
34. Jorgensen JH, Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1992; 14:1119-23
35. Doern GV. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am J Med 1995; 99(suppl 6B):3S-7S
36. American Thoracic Society. Guidelines for initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148:1418-26
37. Derenne JP, Fleury B, Pariente R. Acute respiratory failure of chronic obstructive lung disease. Am Rev Respir Dis 1988; 138:1006-33
38. Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive lung disease. JAMA 1995; 274:1852-57
39. Anthonisen NR, Wright EC, Hodgkin JE, et al. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14-20
40. Ström K. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am Rev Respir Dis 1993; 147:585-91
41. Ball P, Harris JM, Lowson D, et al. Acute infective exacerbations of chronic bronchitis. Q J Med 1995; 88:61-68
42. MacFarlane JT, Colville A, Guion A, et al. Prospective study of aetiology and outcome of adult lower-respiratory tract infections in the community. Lancet 1993; 341:511-14
43. Balter MS, Hyland RH, Low DE, et al. Recommendations on the management of chronic bronchitis. Can Med Assoc J 1994; 151(suppl):7-23
44. Wilson R. Outcome predictors in bronchitis. Chest 1995; 108:53S-57S
45. Lode H. Respiratory tract infections: when is antibiotic therapy indicated? Clin Ther 1991; 13:149-56
46. Freund DA, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. Pharmacoeconomics 1992; 1:20-32
47. Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA 1989; 262:2879-86
48. 1: the Lung Health Study. JAMA 1994; 272:1497-1505
49. Dockery DW, Speizer FE, Ferris BG Jr, et al. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am Rev Respir Dis 1988; 137:286-92
50. Higgins MW, Enright PL, Kronmal RA, et al. Smoking and lung function in elderly men and women: the cardiovascular health study. JAMA 1993; 269:2741-48
51. Wynder EL, Kaufman PL, Lesser RL. A short-term follow-up study on ex-cigarette smokers: with special emphasis on persistent cough and weight gain. Am Rev Respir Dis 1967; 96:645-55
52. Jayanthi V, Probert CSJ, Sher KS, et al. Smoking and prevention. Respir Med 1991; 85:179-83
53. The Smoking Cessation Clinical Practice Guideline Panel and Staff. The agency for health care policy and research smoking cessation clinical practice guideline. JAMA 1996; 275:1270-80
54. Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 1996; 275:1247-51
55. Douglas RG Jr. Prophylaxis and treatment of influenza. N Engl J Med 1990; 322:443-50
56. Niehol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331:778-84
57. Butler JC, Breinan RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270:1826-31
58. Orcel B, Delclaux B, Baud M, et al. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J 1994; 7:446-52
59. Dark D. Azithromycin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis. Curr Ther Res 1993; 53:203-11
60. Neu H, Chick TW. Efficacy and safety of clarithromycin compared to Cefixime as outpatient treatment of lower respiratory tract infections. Chest 1993; 104:1393-99
61. Phillips H, Van Hook CJ, Butler T, et al. A comparison of Cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults. Chest 1993; 104:1387-92
62. Tugwell P, Bennett K, Sackett D. The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions. J Chronic Dis 1985; 38:339-51
63. Wilson R, Tillotson G, Ball P. Clinical studies in chronic bronchitis: a need for better definition and classification of severity. J Antimicrob Chemother 1996; 37:205-07